Drugs in R & D

, Volume 2, Issue 4, pp 281–283 | Cite as

Ursodeoxycholic Acid

Actigall, Urso®, Ursobilane, Ursochol, Ursodesoxycholic Acid, Ursodiol, Ursolite, Ursolvan®
Section 2: Depatitis C Adis R&D Profile


Bile Acid Primary Biliary Cirrhosis Ursodeoxycholic Acid Intrahepatic Cholestasis Urso 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Crosignani A, Setchell KDR, Invernizzi P, et al. Clinical pharmacokinetics of therapeutic bile acids. Clin Pharmacokinet 1996 May; 30: 333–58Google Scholar
  2. 2.
    Ursodeoxycholic acid (ursodiol): currently first choice for primary biliary cirrhosis. Drugs Ther Perspect 1996 Oct 28; 8 (9): 1–5Google Scholar
  3. 3.
    Lilly L, Berg CL, Gollan JL. Primary biliary cirrhosis: immunopathogenesis and optimum management. Clin Immunother 1996 Jun; 5: 420–37CrossRefGoogle Scholar
  4. 4.
    Palma J, Reyes H, Ribalta J, et al. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, doubleblind study controlled with placebo. J Hepatol 1997 Dec; 27: 1022–8PubMedCrossRefGoogle Scholar
  5. 5.
    Abdelmalek MF, Harrison ME, Gross Jr JB, et al. Treatment of chronic hepatitis C with interferon with or without ursodeoxycholic acid: a randomized prospective trial. J Gastroenterol 1998 Mar; 26: 130–4Google Scholar

Copyright information

© Adis International Limited 1999

Personalised recommendations